![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
I.p.s. Ltd Majuro Mh, based in Italy, is a pharmaceutical company.
One of their significant offerings is Progesterone, Micronised, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-081 - Rev 01
This Chemical Type CEP, issued on May 29, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 429 associated with this CEP further emphasizes